Pure desmoplastic melanoma: A melanoma with distinctive clinical behavior

Annals of Surgery

Volumn 252, Issue 6, 2010, Pages 1052-1057

  Maurichi, Andrea ^a   Miceli, Rosalba ^a   Camerini, Tiziana ^a   Contiero, Paolo ^a   Patuzzo, Roberto ^a   Tragni, Gabrina ^a   Crippa, Federica ^a   Romanidis, Konstantinos ^a   Ruggeri, Roberta ^a   Carbone, Antonino ^a   Santinami, Mario ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; DESMOPLASTIC MELANOMA; DISTANT METASTASIS; EXCISION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; MORTALITY; PRIORITY JOURNAL;

AGED; FEMALE; FIBROSIS; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 78650129701     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181efc23c     Document Type: Article

References (28)

1. Conley J, Lattes R, Orr W. Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma). Cancer. 1971;28:914-936.
2. McCarthy SW, Scolyer RA, Palmer AA. Desmoplastic melanoma: a diagnostic trap for the unwary. Pathology. 2004;36:445-451. (Pubitemid 39273988)
3. Lens MB, Newton-Bishop JA, Boon AP. Desmoplastic malignant melanoma: a systematic review. Br J Dermatol. 2005;152:673-678. (Pubitemid 40571298)
4. Carlson JA, Dickersin GR, Sober AJ, et al. Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases. Cancer. 1995;75: 478-494.
5. Quinn MJ, Crotty KA, Thompson JF, et al. Desmoplastic and desmoplas-tic neurotropic melanoma: experience with 280 patients. Cancer. 1998;83: 1128-1135. (Pubitemid 28419065)
6. Payne WG, Kearney R, Wells K, et al. Desmoplastic melanoma. Am Surg. 2001;67:1004-1006. (Pubitemid 33738135)
7. Jaroszewski DE, Pockaj BA, DiCaudo DJ, et al. The clinical behavior of desmo-plastic melanoma. Am J Surg. 2001;182:590-595.
8. Su LD, Fullen DR, Lowe L, et al. Desmoplastic and neurotropic melanoma. Cancer. 2004;100:598-604.
9. Gyorki DE, Busam K, Panageas K, et al. Sentinel lymph node biopsy for patients with cutaneous desmoplastic melanoma. Ann Surg Oncol. 2003;10: 403-407. (Pubitemid 40486938)
10. Thelmo MC, Sagebiel RW, Treseler PA, et al. Evaluation of sentinel lymph node status in spindle cell melanomas. J Am Acad Dermatol. 2001;44: 451-455. (Pubitemid 32199964)
11. Livestro DP, Muzikansky A, Kaine EM, et al. Biology of desmoplastic melanoma: a case-control comparison with other melanomas. J Clin Oncol. 2005;23:6739-6746. (Pubitemid 46190269)
12. Busam KJ, Mujumdar U, Hummer AJ, et al. Cutaneous desmoplastic melanoma: reappraisal of morphologic heterogeneity and prognostic factors. Am J Surg Pathol. 2004;28:1518-1525. (Pubitemid 39425520)
13. Busam KJ. Cutaneous desmoplastic melanoma. Adv Anat Pathol. 2005;12: 92-102. (Pubitemid 40515797)
14. Hawkins WG, Busam KJ, Ben-Porat L, et al. Desmoplastic melanoma: a pathologically and clinically distinct form of cutaneous melanoma. Ann Surg Oncol. 2005;12:207-221.
15. Thompson JF, Scolyer RA, Uren RF. Surgical management of primary cutaneous melanoma: excision margins and the role of sentinel lymph node examination. Surg Oncol Clin N Am. 2006;15:301-318.
16. Balch CM, Urist MM, Karakousis CP, et al. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial. Ann Surg. 1993;218: 262-267.
17. Thomas JM, Newton-Bishop J, A'Hern R, et al. Excision margins in high-risk malignant melanoma. N Engl J Med. 2004;350:757-766. (Pubitemid 38209645)
18. Veronesi U, Cascinelli N. Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma. Arch Surg. 1991;126:438-441.
19. Eng W, Tschen JA. Comparison of S-100 versus hematoxylin and eosin staining for evaluating dermal invasion and peripheral margins by desmo-plastic malignant melanoma. Am J Dermatopathol. 2000;22:26-29. (Pubitemid 30109079)
20. Marubini E, Valsecchi MG. Analyzing Survival Data for Clinical Trials and Observational Studies. Chichester, United Kingdom: John Wiley and Sons; 1995.
21. Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141-1154.
22. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of competing risk. J Am Stat Assoc. 1999;94:496-509.
23. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69:239-241.
24. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med. 1989;8:551-561. (Pubitemid 19116001)
25. R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. Available at: http://www.R-project.org. Accessed March 10, 2009.
26. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American joint committee on cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19:3635-3648. (Pubitemid 32786276)
27. Winnepenninckx V, De Vos R, Stas M, et al. New phenotypical and ultra-structural findings in spindle cell (desmoplastic/neurotropic) melanoma. Appl Immunohistochem Mol Morphol. 2003;11:319-325. (Pubitemid 37522682)
28. Pawlik TM, Ross MI, Prieto VG, et al. Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma. Cancer. 2006;106:900-906. (Pubitemid 43238458)